相关实验视频
Updated: Jun 5, 2025

Microfluidics in Assessing Platelet Function
Published on: November 8, 2024
血液成分输血对产后出血中的凝血功能的影响
Tianming Yan1, Huiqun Xu2, Fengling Li1
1Department of Blood Transfusion, The First Affiliated Hospital of Xiamen University, Xiamen, China.
血液成分输血有效地治疗产后出血 (PPH). 红血细胞与冷凝液的比例为1:1,显著改善了凝血,证明了PPH的有价值的临床治疗方法.
科学领域:
- 产科和妇科 产科和妇科
- 血液学 血液学 血液学
- 输血医学 输血医学
背景情况:
- 产后出血 (PPH) 是一个重要的产科并发症.
- 有效管理PPH对于孕产妇健康至关重要.
- 血液成分输血是PPH的主要治疗方式.
研究的目的:
- 分析血液成分输血在PPH患者的有效性.
- 评估输血对PPH患者凝血功能的影响.
- 为了确定治疗PPH的最佳血液成分比率.
主要方法:
- 从2021年1月至2021年12月期间接受治疗的84名PPH患者的临床数据的回顾性分析.
- 对接受红细胞 (RBC) 和冷流体输血的患者的评估.
- 输血前后凝血参数的比较.
主要成果:
- 输血时,红细胞与冷沉积物的比例为1:1,导致凝血水平显著改善.
- 适当比例的红血细胞,血和冷沉液的联合输血有效地增强了凝血功能.
- 该疗法在管理PPH方面显示出积极的临床效果.
结论:
- 血液成分输血,特别是具有特定的红细胞,血和冷沉积物比率,有效改善产后出血中的凝血.
- 这种治疗方法显示出希望,并保证了更广泛的临床采用.
- 优化的血液成分输血策略对于有效管理PPH至关重要.
更多相关视频
10:25Microfluidic Flow Chambers Using Reconstituted Blood to Model Hemostasis and Platelet Transfusion In Vitro
Published on: March 19, 2016
09:38A Microfluidic Flow Chamber Model for Platelet Transfusion and Hemostasis Measures Platelet Deposition and Fibrin Formation in Real-time
Published on: February 14, 2017
相关概念视频
Coagulation
During the coagulation phase, clotting factors, or procoagulants, play a vital role in initiating and progressing the coagulation cascade. This cascade is a series of reactions...
Extrinsic and Intrinsic Pathways of Hemostasis
The Extrinsic Pathway
The extrinsic pathway of coagulation is typically initiated by tissue damage that exposes blood to tissue factor (TF), a protein released by the damaged tissue cells outside the blood vessels—this interaction with TF triggers biochemical reactions involving specific clotting factors. The key player here is Factor VII, which...
Introduction to Hemostasis
The three phases of hemostasis involve many clotting factors present in plasma and several substances released by platelets and injured tissue cells. It is a fast, localized,...
Blood Transfusion and Agglutination
History
The history of blood transfusion dates back to the 17th century, when early attempts were made in animals. In 1818 James Blundell, a British doctor, performed the first successful human blood transfusion. Later in 1900, Karl...
Anticoagulant Drugs: Low-Molecular-Weight Heparins
Disorders of Hemostasis
Thromboembolic Disorders
Two factors primarily cause thromboembolic conditions.